Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...
The new healthcare information and data environment that Europe intends to develop "will be the driving force behind healthcare research, the development of digital technologies and...
Reig Jofre reported a profit of €4.2 million between January and September 2022, 16% less than in the same period of 2021. The company justifies this...
Following these results, Almirall has confirmed its financial estimates for 2022. Investment in research and development (R&D) increased by 11.3% in the period, to €71.6 million...
Following the latest closing, all previous major investors in the Oltre III fund were confirmed, including the European Investment Fund (EIF), which participated in raising €30...
Arthex Biotech is a spin-off of the University of Valencia (UV). Incorporated in September 2019, the company has its focus on the development of a treatment...
Methinks can effectively detect arterial occlusion in patients with suspected acute ischemic stroke. In addition, CT image processing time is less than two minutes. The software...
The service, also known as AlphaID At Home, is Grifols' first FDA-cleared service for direct-to-consumer use. It will be available beginning in the second quarter of...
Tucuvi has monitored more than 17,000 patients and has worked on more than eight different pathologies. The startup's business model is that of a B2B2C. Customers...
In the cardiovascular area, Microsoft's Healthcare AI Network and Apollo Hospitals are developing a machine learning model to better predict heart attack risk. The use of...